Table 6.
Clinical trial (CT) characteristic |
eThekwini Metro, South Africa (n=281) |
eThekwini Metro, South Africa (n=222)5 |
Pretoria, South Africa (n=67) 13 |
Kano, Northwest Nigeria (n=430) 8 |
Kabarole District, Western Uganda (n=137) 7 |
Period of study | Current study | 2008 | 2004–2005 | 2014 | 2004 |
Setting | Urban | Urban | Urban | Urban | Rural |
Concurrent ATM and ARV use |
4.98% | 44.4% | 4.40% | 4.30% | 32.80% |
ATM use after HIV diagnosis (before initiation of ARV) |
77.60% | - | - | 20.90% | 63.50% |
ATM use before HIV diagnosis |
65.80% | - | - | 27.50% | 90.40% |